Zai Lab (ZLAB) Net Margin (2019 - 2026)
Zai Lab (ZLAB) posted quarterly Net Margin of 51.22% for Q1 2026, down 573.0% year-on-year from 10.83% in Q1 2025, and down 29.64% on a QoQ basis from 39.51% in Q4 2025.
Zai Lab (ZLAB) Net Margin (2019 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Net Margin for 8 consecutive years, with 51.22% the latest figure, recorded in Q1 2026.
- Quarterly Net Margin fell 573.0% year-over-year to 51.22% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 39.29% (up 2096.0% YoY) and the FY2025 annual result came in at 38.15%, up 2629.0% from the prior year.
- Net Margin declined to 51.22% in Q1 2026 per ZLAB's latest filing, from 39.51% in the prior quarter.
- Over the last five years, Net Margin for ZLAB reached as high as 30.98% in Q3 2025 and fell as low as 286.31% in Q2 2022.
- A 5-year average of 105.95% and a median of 78.26% in 2023 frame the typical range for Net Margin.
- The largest YoY upside for Net Margin was 98224 bps in 2022 against a maximum downside of 5646 bps in 2022.
- Year by year, Net Margin stood at 98.67% in 2022, then tumbled by 47 bps to 144.96% in 2023, then surged by 48 bps to 74.89% in 2024, then soared by 47 bps to 39.51% in 2025, then dropped by 30 bps to 51.22% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 51.22%, 39.51%, and 30.98% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -51.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.22% |
| Dec 31, 2025 | -39.51% |
| Sep 30, 2025 | -30.98% |
| Jun 30, 2025 | -37.03% |
| Mar 31, 2025 | -45.49% |
| Dec 31, 2024 | -74.89% |
| Sep 30, 2024 | -40.75% |
| Jun 30, 2024 | -79.87% |
| Mar 31, 2024 | -61.36% |
| Dec 31, 2023 | -144.96% |
| Sep 30, 2023 | -99.89% |
| Jun 30, 2023 | -175.56% |
| Mar 31, 2023 | -78.26% |
| Dec 31, 2022 | -98.67% |
| Sep 30, 2022 | -280.14% |
| Jun 30, 2022 | -286.31% |
| Mar 31, 2022 | -176.34% |
| Dec 31, 2021 | -481.81% |
| Sep 30, 2021 | -223.68% |
| Jun 30, 2021 | -442.19% |